← Eichor
Study identifier: NCT05618002 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Lemborexant vs Zopiclone vs Clonidine for Insomnia Treatment in Chronic Pain Patients

Condition: Chronic Insomnia · Chronic Pain  ·  Sponsor: Salem Anaesthesia Pain Clinic

PhaseN/A
Planned participants150
Who can joinAll sexes, 20 Years to 99 Years
Healthy volunteersYes

About this study

Prospective observational crossover study of 150 consenting adult patients who are undergoing chronic pain management. For insomnia treatment, each patient ingests prescribed doses of Lemborexant or Zopiclone or Clonidine on alternate nights. Each patient uses a special validated sleep diary to collect data including pain score, sleep score, sleep duration, sleep medication type, and adverse effects. Each patient completes the diary for 3 continuous weeks. Pain is measured using the numeric pain rating scale. Sleep score is measured using the Likert sleep scale. A change in the pain or sleep scores by 2-points is considered significant.

This description comes directly from the study's public registry record.

Talk to the study team

Olu Bamgbade, MD,FRCPC  ·  +17786286600  ·  salem.painclinic@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Salem Anaesthesia Pain ClinicSurrey, British Columbia, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05618002